Abstract:Background: Deep learning's automatic feature extraction has proven to give superior performance in many sequence classification tasks. However, deep learning models generally require a massive amount of data to train, which in the case of Hemolytic Activity Prediction of Antimicrobial Peptides creates a challenge due to the small amount of available data. Results: Three different datasets for hemolysis activity prediction of therapeutic and antimicrobial peptides are gathered and the AMPDeep pipeline is implemented for each. The result demonstrate that AMPDeep outperforms the previous works on all three datasets, including works that use physicochemical features to represent the peptides or those who solely rely on the sequence and use deep learning to learn representation for the peptides. Moreover, a combined dataset is introduced for hemolytic activity prediction to address the problem of sequence similarity in this domain. AMPDeep fine-tunes a large transformer based model on a small amount of peptides and successfully leverages the patterns learned from other protein and peptide databases to assist hemolysis activity prediction modeling. Conclusions: In this work transfer learning is leveraged to overcome the challenge of small data and a deep learning based model is successfully adopted for hemolysis activity classification of antimicrobial peptides. This model is first initialized as a protein language model which is pre-trained on masked amino acid prediction on many unlabeled protein sequences in a self-supervised manner. Having done so, the model is fine-tuned on an aggregated dataset of labeled peptides in a supervised manner to predict secretion. Through transfer learning, hyper-parameter optimization and selective fine-tuning, AMPDeep is able to achieve state-of-the-art performance on three hemolysis datasets using only the sequence of the peptides. This work assists the adoption of large sequence-based models for peptide classification and modeling tasks in a practical manner.

HAPPENN is a novel tool for hemolytic activity prediction for therapeutic peptides which employs neural networks

Prediction of Hemolysis Tendency of Peptides using a Reliable Evaluation Method

ENNAVIA is a novel method which employs neural networks for antiviral and anti-coronavirus activity prediction for therapeutic peptides

Enhanced prediction of hemolytic activity in antimicrobial peptides using deep learning-based sequence analysis

Predicting antibacterial activity, efficacy, and hemotoxicity of peptides using an explainable machine learning framework

HLPpred-Fuse: improved and robust prediction of hemolytic peptide and its activity by fusing multiple feature representation

A New Robust Method for Predicting Hemolytic Toxicity from Peptide Se-quence

Peptide hemolytic activity analysis using visual data mining of similarity-based complex networks

Machine learning-guided discovery and design of non-hemolytic peptides

A Method for Predicting Hemolytic Potency of Chemically Modified Peptides From Its Structure

Ensemble Machine Learning and Predicted Properties Promote Antimicrobial Peptide Identification

PepNet: an interpretable neural network for anti-inflammatory and antimicrobial peptides prediction using a pre-trained protein language model

Prediction of Hemolytic Peptides and their Hemolytic Concentration (HC50)

Hybrid transformer-CNN model for accurate prediction of peptide hemolytic potential

AutoPeptideML: A study on how to build more trustworthy peptide bioactivity predictors

AMPDeep: hemolytic activity prediction of antimicrobial peptides using transfer learning

deepAMPNet: a novel antimicrobial peptide predictor employing AlphaFold2 predicted structures and a bi-directional long short-term memory protein language model

HybAVPnet: a Novel Hybrid Network Architecture for Antiviral Peptides Prediction

Machine learning application to predict binding affinity between peptide containing non-canonical amino acids and HLA0201

HLA class I binding prediction via convolutional neural networks

AMP0: Species-Specific Prediction of Anti-microbial Peptides using Zero and Few Shot Learning